LGND logo

LGND Gross profit

Annual gross profit:

$156.06M+$35.26M(+29.19%)
December 31, 2024

Summary

  • As of today (May 24, 2025), LGND annual gross profit is $156.06 million, with the most recent change of +$35.26 million (+29.19%) on December 31, 2024.
  • During the last 3 years, LGND annual gross profit has fallen by -$23.31 million (-13.00%).
  • LGND annual gross profit is now -36.33% below its all-time high of $245.12 million, reached on December 31, 2018.

Performance

LGND Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

quarterly gross profit:

$40.48M+$509.00K(+1.27%)
March 31, 2025

Summary

  • As of today (May 24, 2025), LGND quarterly gross profit is $40.48 million, with the most recent change of +$509.00 thousand (+1.27%) on March 31, 2025.
  • Over the past year, LGND quarterly gross profit has increased by +$12.39 million (+44.09%).
  • LGND quarterly gross profit is now -54.47% below its all-time high of $88.91 million, reached on June 30, 2018.

Performance

LGND quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

TTM gross profit:

$168.45M+$12.39M(+7.94%)
March 31, 2025

Summary

  • As of today (May 24, 2025), LGND TTM gross profit is $168.45 million, with the most recent change of +$12.39 million (+7.94%) on March 31, 2025.
  • Over the past year, LGND TTM gross profit has increased by +$59.81 million (+55.06%).
  • LGND TTM gross profit is now -31.28% below its all-time high of $245.12 million, reached on December 31, 2018.

Performance

LGND TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

LGND Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.2%+44.1%+55.1%
3 y3 years-13.0%+27.2%+2.6%
5 y5 years+43.3%+42.2%+72.3%

LGND Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.0%+29.2%-18.0%+63.9%at high+55.1%
5 y5-year-13.0%+43.3%-25.1%+63.9%-11.3%+72.3%
alltimeall time-36.3%+1468.9%-54.5%+772.5%-31.3%+1577.6%

LGND Gross profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$40.48M(+1.3%)
$168.45M(+7.9%)
Dec 2024
$156.06M(+29.2%)
$39.98M(-19.0%)
$156.06M(+9.5%)
Sep 2024
-
$49.36M(+27.8%)
$142.54M(+16.3%)
Jun 2024
-
$38.63M(+37.5%)
$122.56M(+12.8%)
Mar 2024
-
$28.10M(+6.2%)
$108.64M(-10.1%)
Dec 2023
$120.80M(-15.8%)
$26.46M(-9.9%)
$120.80M(-1.9%)
Sep 2023
-
$29.38M(+19.0%)
$123.11M(-11.3%)
Jun 2023
-
$24.70M(-38.7%)
$138.79M(-8.6%)
Mar 2023
-
$40.26M(+40.0%)
$151.86M(+5.9%)
Dec 2022
$143.42M(-20.0%)
$28.77M(-36.2%)
$143.42M(+2.8%)
Sep 2022
-
$45.07M(+19.3%)
$139.55M(-5.6%)
Jun 2022
-
$37.77M(+18.7%)
$147.87M(-9.9%)
Mar 2022
-
$31.82M(+27.8%)
$164.19M(-8.5%)
Dec 2021
$179.37M(+34.7%)
$24.90M(-53.4%)
$179.37M(-5.5%)
Sep 2021
-
$53.39M(-1.3%)
$189.86M(+10.4%)
Jun 2021
-
$54.08M(+15.1%)
$171.97M(+13.4%)
Mar 2021
-
$47.00M(+32.8%)
$151.66M(+13.9%)
Dec 2020
$133.14M(+22.2%)
$35.39M(-0.3%)
$133.14M(+8.4%)
Sep 2020
-
$35.49M(+5.1%)
$122.81M(+12.7%)
Jun 2020
-
$33.78M(+18.6%)
$108.98M(+11.4%)
Mar 2020
-
$28.48M(+13.6%)
$97.79M(-10.2%)
Dec 2019
$108.94M(-55.6%)
$25.07M(+15.7%)
$108.94M(-22.5%)
Sep 2019
-
$21.66M(-4.1%)
$140.50M(-13.8%)
Jun 2019
-
$22.58M(-43.0%)
$163.05M(-28.9%)
Mar 2019
-
$39.63M(-30.0%)
$229.37M(-6.4%)
Dec 2018
$245.12M(+80.6%)
$56.63M(+28.1%)
$245.12M(+3.3%)
Sep 2018
-
$44.20M(-50.3%)
$237.21M(+5.9%)
Jun 2018
-
$88.91M(+60.6%)
$223.99M(+38.1%)
Mar 2018
-
$55.37M(+13.6%)
$162.18M(+19.5%)
Dec 2017
$135.74M(+31.3%)
$48.73M(+57.2%)
$135.73M(+11.0%)
Sep 2017
-
$30.99M(+14.4%)
$122.30M(+9.3%)
Jun 2017
-
$27.09M(-6.3%)
$111.93M(+8.0%)
Mar 2017
-
$28.93M(-18.0%)
$103.64M(+0.2%)
Dec 2016
$103.40M(+56.4%)
$35.29M(+71.1%)
$103.40M(+16.9%)
Sep 2016
-
$20.62M(+9.7%)
$88.42M(+4.9%)
Jun 2016
-
$18.80M(-34.5%)
$84.25M(+3.7%)
Mar 2016
-
$28.69M(+41.3%)
$81.27M(+22.9%)
Dec 2015
$66.11M(+19.3%)
$20.31M(+23.4%)
$66.11M(+2.0%)
Sep 2015
-
$16.45M(+4.0%)
$64.79M(+4.8%)
Jun 2015
-
$15.82M(+16.9%)
$61.82M(+11.5%)
Mar 2015
-
$13.53M(-28.8%)
$55.42M(+0.0%)
Dec 2014
$55.40M(+28.1%)
$19.00M(+41.0%)
$55.40M(+11.2%)
Sep 2014
-
$13.48M(+43.0%)
$49.83M(+6.4%)
Jun 2014
-
$9.42M(-30.2%)
$46.82M(+2.3%)
Mar 2014
-
$13.51M(+0.6%)
$45.76M(+5.8%)
Dec 2013
$43.24M(+55.6%)
$13.42M(+28.2%)
$43.24M(+5.1%)
Sep 2013
-
$10.47M(+25.1%)
$41.13M(+13.1%)
Jun 2013
-
$8.37M(-23.9%)
$36.35M(+9.2%)
Mar 2013
-
$10.99M(-2.8%)
$33.29M(+19.8%)
Dec 2012
$27.79M(+10.6%)
$11.31M(+98.6%)
$27.79M(+1.6%)
Sep 2012
-
$5.69M(+7.3%)
$27.36M(+2.4%)
Jun 2012
-
$5.31M(-3.2%)
$26.70M(-2.0%)
Mar 2012
-
$5.48M(-49.6%)
$27.24M(+8.4%)
Dec 2011
$25.13M(+6.8%)
$10.88M(+115.9%)
$25.13M(+38.1%)
Sep 2011
-
$5.04M(-13.7%)
$18.19M(-13.2%)
Jun 2011
-
$5.84M(+73.2%)
$20.95M(+0.0%)
Mar 2011
-
$3.37M(-14.4%)
$20.95M(-11.0%)
DateAnnualQuarterlyTTM
Dec 2010
$23.54M(-39.6%)
$3.94M(-49.5%)
$23.54M(-29.9%)
Sep 2010
-
$7.80M(+33.6%)
$33.58M(-0.3%)
Jun 2010
-
$5.84M(-2.0%)
$33.67M(-5.0%)
Mar 2010
-
$5.96M(-57.4%)
$35.43M(-9.0%)
Dec 2009
$38.94M(+42.6%)
$13.98M(+76.9%)
$38.94M(+56.0%)
Sep 2009
-
$7.90M(+4.0%)
$24.96M(+46.3%)
Jun 2009
-
$7.59M(-19.8%)
$17.06M(+80.2%)
Mar 2009
-
$9.47M(+94.3%)
$9.47M(+94.3%)
Dec 2008
$27.32M(+111.8%)
-
-
Mar 2008
-
$4.87M(-80.9%)
$4.87M(-95.6%)
Dec 2007
$12.89M(-86.3%)
-
-
Sep 2005
-
$25.58M(-27.2%)
$111.10M(+3.2%)
Jun 2005
-
$35.13M(+35.5%)
$107.64M(+13.2%)
Mar 2005
-
$25.92M(+5.9%)
$95.06M(-20.1%)
Dec 2004
$93.85M(+72.0%)
$24.47M(+10.6%)
$119.01M(+34.4%)
Sep 2004
-
$22.11M(-2.0%)
$88.52M(-0.7%)
Jun 2004
-
$22.56M(-54.8%)
$89.12M(+1.4%)
Mar 2004
-
$49.87M(-928.4%)
$87.93M(+61.2%)
Dec 2003
$54.56M(-4.3%)
-$6.02M(-126.5%)
$54.56M(-13.5%)
Sep 2003
-
$22.72M(+6.4%)
$63.08M(+5.2%)
Jun 2003
-
$21.36M(+29.4%)
$59.98M(+12.9%)
Mar 2003
-
$16.50M(+559.9%)
$53.11M(-6.9%)
Dec 2002
$57.03M(-8.6%)
$2.50M(-87.3%)
$57.03M(-21.6%)
Sep 2002
-
$19.62M(+35.5%)
$72.79M(+6.0%)
Jun 2002
-
$14.48M(-29.1%)
$68.70M(-1.2%)
Mar 2002
-
$20.43M(+11.9%)
$69.56M(+8.2%)
Dec 2001
$62.39M(+57.9%)
$18.26M(+17.6%)
$64.27M(+11.6%)
Sep 2001
-
$15.53M(+1.2%)
$57.58M(+7.8%)
Jun 2001
-
$15.35M(+1.4%)
$53.40M(+5.0%)
Mar 2001
-
$15.13M(+30.8%)
$50.84M(+11.6%)
Dec 2000
$39.52M(+30.0%)
$11.57M(+1.9%)
$45.54M(+35.9%)
Sep 2000
-
$11.35M(-11.2%)
$33.51M(+2.1%)
Jun 2000
-
$12.79M(+30.1%)
$32.83M(+11.5%)
Mar 2000
-
$9.83M(-2233.0%)
$29.44M(-3.2%)
Dec 1999
$30.41M(+37.0%)
-$461.00K(-104.3%)
$30.40M(-11.3%)
Sep 1999
-
$10.66M(+13.5%)
$34.27M(+16.9%)
Jun 1999
-
$9.40M(-13.0%)
$29.30M(+12.3%)
Mar 1999
-
$10.80M(+217.6%)
$26.10M(+17.6%)
Dec 1998
$22.20M(-63.9%)
$3.40M(-40.4%)
$22.20M(-48.7%)
Sep 1998
-
$5.70M(-8.1%)
$43.30M(-13.9%)
Jun 1998
-
$6.20M(-10.1%)
$50.30M(-10.7%)
Mar 1998
-
$6.90M(-71.8%)
$56.30M(-8.5%)
Dec 1997
$61.50M(+33.1%)
$24.50M(+92.9%)
$61.50M(+25.3%)
Sep 1997
-
$12.70M(+4.1%)
$49.10M(-3.9%)
Jun 1997
-
$12.20M(+0.8%)
$51.10M(+5.1%)
Mar 1997
-
$12.10M(0.0%)
$48.60M(+4.7%)
Dec 1996
$46.20M(+63.8%)
$12.10M(-17.7%)
$46.40M(+6.9%)
Sep 1996
-
$14.70M(+51.5%)
$43.40M(+19.9%)
Jun 1996
-
$9.70M(-2.0%)
$36.20M(+36.6%)
Mar 1996
-
$9.90M(+8.8%)
$26.50M(+21.0%)
Dec 1995
$28.20M(-347.4%)
$9.10M(+21.3%)
$21.90M(+92.1%)
Sep 1995
-
$7.50M(+41.5%)
$11.40M(-556.0%)
Mar 1995
-
$5.30M(-478.6%)
-$2.50M(-78.1%)
Dec 1994
-$11.40M
-$1.40M(-48.1%)
-$11.40M(+14.0%)
Sep 1994
-
-$2.70M(-27.0%)
-$10.00M(+37.0%)
Jun 1994
-
-$3.70M(+2.8%)
-$7.30M(+102.8%)
Mar 1994
-
-$3.60M
-$3.60M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual gross profit?
  • What is the all time high annual gross profit for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual gross profit year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly gross profit?
  • What is the all time high quarterly gross profit for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly gross profit year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated TTM gross profit?
  • What is the all time high TTM gross profit for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated TTM gross profit year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual gross profit?

The current annual gross profit of LGND is $156.06M

What is the all time high annual gross profit for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual gross profit is $245.12M

What is Ligand Pharmaceuticals Incorporated annual gross profit year-on-year change?

Over the past year, LGND annual gross profit has changed by +$35.26M (+29.19%)

What is Ligand Pharmaceuticals Incorporated quarterly gross profit?

The current quarterly gross profit of LGND is $40.48M

What is the all time high quarterly gross profit for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly gross profit is $88.91M

What is Ligand Pharmaceuticals Incorporated quarterly gross profit year-on-year change?

Over the past year, LGND quarterly gross profit has changed by +$12.39M (+44.09%)

What is Ligand Pharmaceuticals Incorporated TTM gross profit?

The current TTM gross profit of LGND is $168.45M

What is the all time high TTM gross profit for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high TTM gross profit is $245.12M

What is Ligand Pharmaceuticals Incorporated TTM gross profit year-on-year change?

Over the past year, LGND TTM gross profit has changed by +$59.81M (+55.06%)
On this page